23-Jun-2017 - Waters Corporation

Waters Corporation elects Flemming Ornskov to Board of Directors

Waters Corporation announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today.

"It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President and CEO. "Flemming's broad, global leadership experience in the biopharmaceutical industry will add great value to Waters' strategic and governance processes. Moreover, Flemming's strong character and passion for human health make him a great addition to Waters' values-oriented culture."

“I have been impressed with the Waters Corporation’s support for researchers and organizations whose innovative work helps heal, feed and protect people around the world,” said Shire’s Flemming Ornskov, M.D., M.P.H. “I look forward to working with Chris and the entire Board in pursuing a bright future for the Company, its employees and those they serve.”

Dr. Ornskov was appointed Chief Executive Officer of Shire plc in April, 2013, where he serves as Chairman of the Executive Committee, and is a member of the Board of Directors. Dr. Ornskov brings broad operational and medical knowledge, and extensive international, strategic and operational experience in the pharmaceutical sector. Prior to Shire, Dr. Ornskov held key executive leadership positions at Bayer, Bausch & Lomb, Inc., Merck & Co., Inc. and Novartis AG. Dr. Ornskov received his MD from the University of Copenhagen, his MBA from INSEAD, and his Master of Public Health from Harvard University. Before his business career, Dr. Ornskov, trained as an intern and resident in pediatrics at the University Hospital of Copenhagen.

Facts, background information, dossiers
  • Flemming Ornskov
  • Christopher J. O'Connell
  • Waters
  • personnel changes
More about Waters
  • News

    Waters Corporation Names Udit Batra President and Chief Executive Officer

    Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as Pr ... more

    Waters to Acquire Andrew Alliance

    Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

    Waters acquires DESI-MS technology from Prosolia

    Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more

  • Products

    Making Liquid Chromatography and High-Resolution Mass Spectrometry (LC-MS) Smarter for Biopharma

    Monitor biopharma critical quality attributes for drug release Use LC-MS for routine analyses without tedious optimization Self-calibrating, self-troubleshooting and easy to maintenance more

  • Catalogs

    Waters Quality Parts, Chromatography Columns and Supplies Catalog

    Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more

  • Videos

    Making Liquid Chromatography and High-Resolution Mass Spectrometry (LC-MS) Smarter for Biopharma

    For biopharmaceutical organizations who need the power and performance of LC-MS for routine screening and multi-attribute monitoring (MAM), with the BioAccord™ Waters has designed the first SmartMS™-enabled biopharma LC-MS solution. We’re used to turning on a device and using it immediately ... more

    Self-optimizing LC-MS System for Biopharmaceutical Analyses

    The BioAccord system enables even users without expert knowledge to generate and evaluate LC-MS data on the spot in the biopharmaceutical lab, tasks that until now had to be performed in centralized MS laboratories. From development to QC, the system makes the analysis of biotherapeutic pro ... more

    The Solution for Your Daily Bioseparations Challenges

    Engineered with bio-inert flow paths made of non-stainless-steel and iron-free materials, the ACQUITY Arc Bio System keeps large molecules intact and on the move, for better sample recovery and minimal carryover, whether the chromatographic mode is reversed phase (RP), ion exchange (IEX), s ... more

  • Companies

    Waters GmbH

    For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance. Waters designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid ... more

    Waters SpA

    Since 1958, Waters has offered total solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ... more

    Waters Ges.m.b.H.

    Since 1958 Waters offers complete solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ha ... more